NCT06844838 (FasTrack) is a clinical trial in Supratentorial Brain Tumor Surgery, sponsored by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta.

Who is sponsoring NCT06844838?

NCT06844838 is sponsored by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta.

What condition does NCT06844838 study?

NCT06844838 studies Supratentorial Brain Tumor Surgery.

Is NCT06844838 still recruiting?

NCT06844838 is currently recruiting now. Last updated 11 February 2026.

Last reviewed 2026-02-11 · How we verify

NCT06844838: FasTrack

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FASt Track in Elective Neurosurgery: the Role of Low Propofol Bis-NOL Guided General Anaesthesia for Full, Early and Safe Awakening

Recruiting now Last updated 11 February 2026

What this trial tests

trial in Supratentorial Brain Tumor Surgery in 100 participants. Currently enrolling.

Timeline

19 January 2024

Primary endpoint
31 December 2025

1 February 2026

Quick facts

Lead sponsor	Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	100
Start date	19 January 2024
Primary completion	31 December 2025
Estimated completion	1 February 2026
Sites	1 location across Italy

Conditions studied

Supratentorial Brain Tumor Surgery — all drugs for Supratentorial Brain Tumor Surgery →

Sponsor

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta — full company profile →

Who can join

18 and older, any sex, with Supratentorial Brain Tumor Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the effect of intraoperative sedation dosage on awakening and recovery of consciousness after elective neurosurgical surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta trials

Trials by the same sponsor.

NCT07168850 — Focused Ultrasound Unilateral Pallidotomy for Medication-Refractory Limb Dystonia · NA · recruiting
NCT06699095 — Home Rehabilitation As Continuity of Care in MS · NA · recruiting
NCT06933212 — Effect of the Mediterranean Diet in Patients Affected by CADASIL and Cerebral Amyloid Angiopathy. · recruiting
NCT06584097 — COMparative Performance of General Purpose Models · recruiting
NCT07427940 — Omic Profile in Autism Spectrum Disorder: From Cellular Level Towards Future Treatments · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06844838 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Last refreshed: 11 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06844838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing